Tonix Pharmaceuticals Holding Corp.

NASDAQ: TNXPHealthcare / Drug Manufacturers - Major / USA
1.59-0.0600-3.64%Vol 66 2741Y Perf -96.01%
Jun 14th, 2019 15:59
BID1.57 ASK1.59
Open1.65 Previous Close1.65
Pre-Market1.62 After-Trading1.53
 -0.03 -1.82%  -0.06 -3.77%
Target Price
6.67 
Analyst Rating
Strong Buy 1.00
Potencial %
319.50 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
100/100/100 
Value Ranking
 —    -
Insiders Value % 3/6/12M
100/100/100 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12M
100/100/100 
Income Ranking
 —    -
Market Cap (mil)10 
Earnings Rating
Neutral
Price Range Ratio 52wk %
0.13 
Earnings Date
13th May 2019

Today's Price Range

1.561.65

52wk Range

1.5348.90

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Month
-11.67%
3 Months
-44.79%
6 Months
-43.42%
1 Year
-96.01%
3 Years
-99.35%
5 Years
-99.86%

Name / TickerPriceChg.Chg.%
TNXP1.59-0.0600-3.64
AAPL192.74-1.4100-0.73
GOOG1 085.35-3.4200-0.31
MSFT132.450.13000.10
XOM74.35-0.3300-0.44
WFC45.590.30000.66
JNJ140.09-0.6200-0.44
FB181.333.86002.18
GE10.23-0.0800-0.78
JPM109.820.28000.26
Earnings HistoryEstimateReportedSurprise %
Q01 2019-1.28-1.29-0.78
Q04 2018-3.87-6.10-57.62
Q03 2018-6.50-5.7012.31
Q02 2018-7.60-7.303.95
Q01 2018-7.00-8.80-25.71
Q04 2017-7.70-6.7012.99
Q03 2017-6.80-7.00-2.94
Q02 2017-0.73-0.6510.96
Earnings Per EndEstimateRevision %Trend
6/2019 QR-0.9989.52Positive
9/2019 QR-0.9686.54Positive
12/2019 FY-4.05--
12/2020 FY-2.69--
Next Report Date-
Estimated EPS Next Report-1.27
Estimates Count2
EPS Growth Next 5 Years %-
Volume Overview
Volume66 274
Shares Outstanding (in ths.)6 089
Trades Count164
Dollar Volume101 545
Avg. Volume1 062 285
Avg. Weekly Volume137 862
Avg. Monthly Volume647 060
Avg. Quarterly Volume685 906
Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
3 (100.00 %)
3 (75.00 %)
2 (50.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
1 (25.00 %)
2 (50.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingStrong Buy
1.00
Strong Buy
1.50
Moderate Buy
2.00

Tonix Pharmaceuticals Holding Corp.

Tonix Pharmaceuticals Holding Corp is a clinical-stage pharmaceutical company. The company is focused on delivering an efficacious and safe long-term treatment for PTSD. PTSD is characterized by chronic disability, inadequate treatment options, high utilization of healthcare services, and economic burden.

CEO: Seth Lederman

Teplephone: +1 212 980-9155

Address: 509 Madison Avenue, New York 10022, NY, USA

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

53%47%

Bearish Bullish

58%42%

Bearish Bullish

55%45%

News